Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Seychelles Business Herald.
Press releases published on September 5, 2025

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tronox Holdings
Faruqi …

Old National to Present at the 2025 Barclays Global Financial Services Conference
EVANSVILLE, Ind., Sept. 05, 2025 (GLOBE NEWSWIRE) -- Old National Bancorp (NASDAQ: ONB) announced today that its Chairman and Chief Executive Officer Jim Ryan will present at the 2025 Barclays Global Financial Services Conference in New York, NY at 2:45 p. …

Syntec Optics (Nasdaq: OPTX) Launches Pioneering New York State Apprenticeship Program to Foster U.S. Advanced Manufacturing
ROCHESTER, NEW YORK, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Syntec Optics Holdings, Inc. (Nasdaq: OPTX) (“Syntec Optics” or the “Company”), a leading provider of technology products to defense, biomedical, communications, and consumer industry leaders, today …

Crown Castle to Present at the 2025 RBC Capital Markets Global Communications Infrastructure Conference
HOUSTON, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Crown Castle Inc. (NYSE: CCI) ("Crown Castle") announced today that Sunit Patel, Crown Castle’s Executive Vice President and Chief Financial Officer is scheduled to present on Wednesday, September 17, 2025 at 9: …

dLocal Announces Closing of Secondary Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
MONTEVIDEO, Uruguay, Sept. 05, 2025 (GLOBE NEWSWIRE) -- DLocal Limited (“dLocal”), (NASDAQ:DLO) a technology-first payments platform, today announced the closing of a previously announced secondary offering of 17,250,000 Class A common shares (including 2, …

Spyre Therapeutics Announces Grants of Inducement Awards
WALTHAM, Mass., Sept. 05, 2025 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the “Company” or “Spyre”), a clinical-stage biotechnology company utilizing best-in-class antibody engineering, dose optimization and rational therapeutic …

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced …

RYVYL Appoints George Oliva and Gene Jones to Its Board of Directors
- Genevieve Baer and Ezra Laniado resign from the Board of Directors - SAN DIEGO, CA, Sept. 05, 2025 (GLOBE NEWSWIRE) -- RYVYL Inc. (NASDAQ: RVYL) ("RYVYL” or the "Company") has appointed current CFO George Oliva and Gene Jones to its Board of Directors. …

89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN FRANCISCO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- 89bio, Inc. (the “Company” or “89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and …

Coherent Joins LLNL’s STARFIRE Diode Technology Working Group to Advance Inertial Fusion Energy
SAXONBURG, Pa., Sept. 05, 2025 (GLOBE NEWSWIRE) -- Coherent Corp. (NYSE: COHR), a global leader in photonics, announced today its membership in the Diode Technology Working Group within the STARFIRE Hub, a collaborative initiative led by Lawrence Livermore …

Fundamental Global Inc. Amends its Charter with the State of Nevada
Certificate of Amendment Changes Name to FG Nexus Inc., Increases Authorized Shares, Triggers Conversion of Automatic Exercise Pre-Funded Warrants to Common Stock and Expands Outstanding Share Count to Over 35 million Charlotte, NC, Sept. 05, 2025 (GLOBE …

Gyre Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
SAN DIEGO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), an innovative, commercial-stage biopharmaceutical company dedicated to advancing fibrosis-first therapies across organ systems affected by chronic disease, today …

Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BRISBANE, Calif., Sept. 05, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that, on September 4, 2025, the Compensation Committee of Vera’s Board of Directors granted inducement awards consisting of non-qualified stock …

Rapport Therapeutics to Announce Topline Results for RAP-219 Phase 2a Trial in Focal Onset Seizures on Monday, September 8, 2025
BOSTON and SAN DIEGO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a clinical-stage biotechnology company dedicated to the discovery and development of small molecule precision medicines for …

Artelo Biosciences Announces Closing of $3.0 Million Public Offering
SOLANA BEACH, Calif., Sept. 05, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, dermatologic …

Arvig Launches Digital Life Skills to Boost Digital Literacy, Online Safety for Residents
PERHAM, Minn., Sept. 05, 2025 (GLOBE NEWSWIRE) -- A high-speed internet connection offers unparalleled opportunities for learning, connection and community impact. Yet, to fully realize its wide-reaching potential, this powerful tool requires one essential …

GSR IV Acquisition Corp. Announces the Closing of its $230 Million Initial Public Offering, Including Full-Exercise Of Over-Allotment Option
New York, NY, Sept. 05, 2025 (GLOBE NEWSWIRE) -- GSR IV Acquisition Corp. (NASDAQ: GSRF) (“GSRF” or the “Company”) announced today that it closed its initial public offering of 23,000,000 units at a price of $10.00 per unit, for aggregate gross proceeds of …

Adverum Biotechnologies Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
REDWOOD CITY, Calif., Sept. 05, 2025 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM) today announced that the Compensation Committee of Adverum’s Board of Directors granted inducement awards consisting of non-qualified stock options to …

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
NEW YORK, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that on September 1, 2025 the Company granted inducement awards to …

aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR) (“aTyr” or “the Company”), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase …